Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients

Journal of the European Academy of Dermatology and Venereology : JEADV
G Ginter-HanselmayerJ Smolle

Abstract

Onychomycosis is a rare disease in children with an estimated prevalence ranging from 0% to 2.6%. Thus far, only limited experience with itraconazole and terbinafine treatment in children with onychomycosis is available in the literature. Evaluation of treatment experience with itraconazole or terbinafine in childhood onychomycosis. Thirty-six children and adolescents (aged 4-17 years, 18 males and 18 females) with clinical and mycologically proven onychomycosis were enrolled in the present study. METHODS AND OUTCOME: In 27 of 36 patients, the causative agent (Trichophyton rubrum in 26 cases and Trichophyton interdigitale in one patient) could be identified by means of cultivation. Nineteen patients were treated with itraconazole 200 mg once daily for 12 weeks, and 17 patients were treated with terbinafine for 12 weeks in a dosage according to their body weight, respectively. Clinical cure was achieved within 1 to 5 months after discontinuation in all patients treated with itraconazole and in all but two patients after cessation of terbinafine treatment. Neither in the itraconazole nor in the terbinafine group were serious adverse events reported. Clinical cure was achieved within 1 to 5 months after discontinuation in all pati...Continue Reading

References

Jun 1, 1990·Journal of the American Academy of Dermatology·N S Prose
May 1, 1989·Clinical and Experimental Dermatology·C M Philpot, D Shuttleworth
Mar 1, 1995·The British Journal of Dermatology·J Berth-Jones, P E Hutchinson
Aug 1, 1994·Current Opinion in Pediatrics·J R Rosenthal
Jul 1, 1993·Journal of the American Academy of Dermatology·R J Hay
Feb 1, 1996·Journal of the American Academy of Dermatology·N ZaiasR Baran
Jan 1, 1997·Journal of the American Academy of Dermatology·T Ploysangam, A W Lucky
Oct 20, 1998·Journal of the American Academy of Dermatology·R UngpakornP Kullavanijaya
Jan 6, 1999·Pediatric Dermatology·A K GuptaS L Hofstader
Jun 13, 2000·Archives of Pediatrics & Adolescent Medicine·P H Huang, A S Paller
Jul 14, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·C Peña-PenabadE Fonseca
Mar 22, 2002·Journal of Cutaneous Medicine and Surgery·B Barankin, L Guenther
Feb 12, 2004·Pediatric Dermatology·Aditya K Gupta, Alayne R Skinner
Dec 22, 2005·Mycoses·M LangeB Bykowska
Dec 21, 2006·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Claus SeebacherHans-Jrgen Tietz
Jan 9, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·A BonifazJ Araiza

❮ Previous
Next ❯

Citations

Nov 1, 2011·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·P NenoffH-J Tietz
Oct 16, 2012·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·H-J Tietz, P Nenoff
Oct 12, 2012·Wiener medizinische Wochenschrift·Georgi TchernevNobuo Kanazawa
Oct 2, 2013·Clinics in Dermatology·Aditya K GuptaFiona C Simpson
Jan 3, 2013·Pediatric Dermatology·Aditya K Gupta, Maryse Paquet
Nov 21, 2014·The British Journal of Dermatology·M AmeenM Richardson
Sep 2, 2014·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Pietro NenoffHans-Jürgen Tietz
Apr 22, 2014·Journal de mycologie médicale·S Khebizi, R Mansouri
Apr 29, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Pietro NenoffGabriele Ginter-Hanselmayer
Jan 18, 2017·MMW Fortschritte der Medizin·Hans-Jürgen Tietz
Jun 27, 2018·Pediatric Dermatology·Aditya K GuptaSheila F Friedlander
Jan 29, 2019·Expert Opinion on Pharmacotherapy·Shari R Lipner
Mar 15, 2008·Cognitive Neuropsychology·M Jane RiddochAndrew J Schofield
Aug 18, 2020·The Journal of Dermatological Treatment·Aditya K GuptaVincent Piguet
Feb 26, 2011·American Journal of Clinical Dermatology·Bertrand Richert, Josette André
Jul 22, 2020·Current Opinion in Pediatrics·Robert J Smith, Adam I Rubin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.